December 1, 2023

Two novel biomarkers, lysosome-associated membrane glycoprotein 2 and insulin-like growth factor-binding protein 7, are effective in the diagnosis of multiple sclerosis and neuromyelitis optica spectrum disorder, the latter being associated with superior diagnostic potential.
Multiple Sclerosis
Neurology
Neuromyelitis Optica Spectrum Disorder

Diagnostic Potential of Two Novel Biomarkers for NMOSD and MS

Two novel biomarkers, lysosome-associated membrane glycoprotein 2 and insulin-like growth factor-binding protein 7, are effective in the diagnosis of multiple sclerosis and neuromyelitis optica spectrum disorder, the latter being associated with superior diagnostic potential. Currently, no tests can establish a definitive diagnosis or differentiate between neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS). The...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.